Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
Q2 2022 vs. Q1 2022
How the institutions holding Silence Therapeutics plc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 26 | 25 | −1 |
| Shares | 12.2M | 10.4M | −1.82M (−14.9%) |
| Value | $218.3M | $116.4M | −$101.9M (−46.7%) |
New holders (4)
Institutions that held Silence Therapeutics plc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 28,816 | $341.0K | 0.00% |
| Parkman Healthcare Partners LLC | 26,250 | $311.0K | 0.11% |
| WS Management LLLP | 25,000 | $296.0K | 0.04% |
| Citadel Advisors LLC | 11,441 | $136.0K | 0.00% |
Sold out (5)
Institutions that held Silence Therapeutics plc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Lombard Odier Asset Management (Europe) Ltd | 1,561,551 | $29.7M |
| Altium Capital Management LP | 109,000 | $2.07M |
| Legal & General Group Plc | 14,973 | $288.0K |
| Bank of America Corp | 770 | $15.0K |
| TCI Wealth Advisors, Inc. | 10 | $0 |